Delhi NCR Healthcare

🚀 Building a website? Start with reliable WordPress hosting from MilesWeb →

Business news, market intelligence, and global industry analysis.

The Latest

Nvidia (NVDA) rises on Kyber denial but trails AMD and Broadcom as Rubin Ultra cadence questioned

GoldStone Resources (AIM: GRL) shares jump as Persistence Gold takes 21% stake in AIM miner

Nexsen (ASX: NXN) jumps as StrepSure validation path sharpens

Novartis agrees $1.5bn Myricx Bio deal as ADC platform race intensifies

Fortis Healthcare stock rises as it brings Greater Noida hospital fully under control via 15-year lease

Fortis Healthcare signs 15-year lease for Greater Noida hospital, boosting NCR reach to 2,000 beds. See how this move could drive stock momentum and margins.

byPallavi Madhiraju

September 2, 2025

Artemis Medicare Services secures Rs 330cr from International Finance Corporation

Artemis Medicare Services Ltd. (BSE: 542919 | NSE: ARTEMISMED), a prominent healthcare provider in the Delhi NCR region,…

byPallavi Madhiraju

April 7, 2024

The Latest

Nvidia (NVDA) rises on Kyber denial but trails AMD and Broadcom as Rubin Ultra cadence questioned

GoldStone Resources (AIM: GRL) shares jump as Persistence Gold takes 21% stake in AIM miner

Nexsen (ASX: NXN) jumps as StrepSure validation path sharpens

Novartis agrees $1.5bn Myricx Bio deal as ADC platform race intensifies

Fortis Healthcare stock rises as it brings Greater Noida hospital fully under control via 15-year lease

Artemis Medicare Services secures Rs 330cr from International Finance Corporation

Nvidia (NVDA) rises on Kyber denial but trails AMD and Broadcom as Rubin Ultra cadence questioned

GoldStone Resources (AIM: GRL) shares jump as Persistence Gold takes 21% stake in AIM miner

Nexsen (ASX: NXN) jumps as StrepSure validation path sharpens

Novartis agrees $1.5bn Myricx Bio deal as ADC platform race intensifies

Knights Group revenue jumps 28% as KGH organic growth accelerates to 12%

Genesis Minerals (ASX: GMD) launches A$5.6bn Vault bid as Regis faces five-day test

Solstice to buy Element Solutions for $14.5bn as AI materials strategy faces investor test

Ipsen agrees €700m Memo Therapeutics deal as acquisition spree accelerates